Mouse Anti-LRRC4 Recombinant Antibody (CBYJL-2013) (CBMAB-L2118-YJ)

Liu, Y., Xu, G., Fu, H., Li, P., Li, D., Deng, K., ... & Wu, M. (2023). Membrane-bound transcription factor LRRC4 inhibits glioblastoma cell motility. International Journal of Biological Macromolecules, 246, 125590.

Deng, K., & Wu, M. (2023). Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma. Chinese Medical Journal, 136(01), 4-12.

Zhang, Y., Li, D., Zeng, Q., Feng, J., Fu, H., Luo, Z., ... & Wu, M. (2021). LRRC4 functions as a neuron-protective role in experimental autoimmune encephalomyelitis. Molecular Medicine, 27(1), 1-17.

Feng, J., Ren, X., Fu, H., Li, D., Chen, X., Zu, X., ... & Wu, M. (2021). LRRC4 mediates the formation of circular RNA CD44 to inhibit GBM cell proliferation. Molecular Therapy-Nucleic Acids, 26, 473-487.

Zhao, C., She, X., Zhang, Y., Liu, C., Li, P., Chen, S., ... & Wu, M. (2020). LRRC4 suppresses E-cadherin-dependent collective cell invasion and metastasis in epithelial ovarian cancer. Frontiers in Oncology, 10, 144.

Xue, Y., Xu, T., & Jiang, W. (2020). Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4/SDF-1/CXCR4 signaling pathway. Regenerative therapy, 14, 322-329.

Zhang, Y., Li, D., Zeng, Q., Feng, J., Fu, H., Luo, Z., ... & Wu, M. (2019). Deficiency of LRRC4 Accelerates Experimental Autoimmune Encephalomyelitis by Disrupting Th1/Treg Cell Balance.

Feng, J., Zhang, Y., Ren, X., Li, D., Fu, H., Liu, C., ... & Wu, M. (2019). LRRC4 Act As a Novel Autophagy Inhibitor that Restores Sensitivity of GBMs to Temozolomide. Available at SSRN 3432552.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols